Stock Events

Co-Diagnostics 

$1.34
83
+$0.01+0.37% Friday 20:00

Statistics

Day High
1.38
Day Low
1.29
52W High
2.23
52W Low
0.98
Volume
269,185
Avg. Volume
289,143
Mkt Cap
44.36M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

7
NOV
Earnings
 

Earnings

7NovExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
-0.5
-0.4
-0.3
-0.2
Expected EPS
-0.33
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CODX. It's not an investment recommendation.
Alphabet
72977
GOOGL
Apple
63793
AAPL
Microsoft
59455
MSFT
Amazon
54892
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Qiagen NV
QGEN
Mkt Cap10.16B
QIAGEN offers diagnostic solutions, including molecular diagnostics which directly compete with Co-Diagnostics' testing technologies.
Thermo Fisher Scientific
TMO
Mkt Cap234.95B
Thermo Fisher Scientific provides a broad range of diagnostic and research products, including molecular diagnostics that compete with CODX offerings.
Bio-Rad Laboratories
BIO
Mkt Cap9.35B
Bio-Rad Laboratories offers a variety of diagnostic tests and systems, including PCR-based tests, which are in direct competition with Co-Diagnostics' products.
Hologic
HOLX
Mkt Cap18.87B
Hologic specializes in diagnostics for women's health, including molecular diagnostics, competing in some of the same spaces as Co-Diagnostics.
Quest Diagnostics
DGX
Mkt Cap17.47B
Quest Diagnostics provides diagnostic testing services, including molecular diagnostics, competing with Co-Diagnostics in the laboratory testing market.
Labcorp
LH
Mkt Cap19.3B
Laboratory Corporation of America offers a wide range of diagnostic tests, including molecular diagnostics, making it a competitor in the diagnostics market.
Abbott Laboratories
ABT
Mkt Cap197.08B
Abbott Laboratories offers a broad portfolio of diagnostic products, including molecular diagnostics, competing across several of Co-Diagnostics' market segments.
Agilent Technologies
A
Mkt Cap41.06B
Agilent Technologies provides life sciences, diagnostics, and applied chemical markets with instruments and services, including diagnostics that compete with Co-Diagnostics.
Baxter International
BAX
Mkt Cap19.36B
Baxter International offers a range of medical devices and laboratory equipment, some of which are used in diagnostic applications that compete with Co-Diagnostics.
Roche
RHHBY
Mkt Cap272.83B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, including molecular diagnostics, making it a significant competitor to Co-Diagnostics in the global diagnostics market.

Analyst Ratings

1.5$Average Price Target
The highest estimate is $1.5.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

About

Health Technology
Biotechnology
Manufacturing
Surgical and Medical Instrument Manufacturing
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Show more...
CEO
Dwight Egan
Employees
155
Country
US
ISIN
US1897631057

Listings

LSE
GB
0A50.LSE
F
DE
C97.F
XNAS
US
CODX